跳至主要内容
临床试验/NCT02547532
NCT02547532已完成不适用

Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency

Fondazione Salvatore Maugeri0 个研究点目标入组 100 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
主要终点
composition of microbioma in sputa

研究概览

简要总结

In the context of the increasing evidence of the pathogenetic role of microbiome in COPD, our aim is to determine the total and specific bacterial and viral load in sputa from patients with COPD due to AATD and to correlate these findings with cellular, biochemical and immunological characteristics of sputa. These quantitative data obtained from sputum will be analyzed in the context of the clinical and physiological parameters of the patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of COPD and a clinical stable condition, i.e. at least three months from the last AECOPD and/or antibiotic treatment.
  • For patients with AATD this condition will be diagnosed by laboratory tests showing low levels of AAT and genotyping of AATD-related genes.

排除标准

  • The presence of important co-morbidities (diabetes, systemic or organ infections, immunodeficiency, tumors, moderate-severe heart failure) will be considered as exclusion criteria.

结局指标

主要结局

composition of microbioma in sputa

时间窗: 2 years

次要结局

  • correlation with clinical and physiological parameters(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bruno Balbi

Head, Pulmonary Rehabilitation Department

Fondazione Salvatore Maugeri

相似试验

Microbioma in Sputa From COPD With Alpha-1... | 临床试验